Neuexcell Therapeutics
NeuExcell
Founded 2021 · $25.0M raised
- Founded
- 2021
- Website
- neuexcell.com
- Total Funding
- $25.0M
- Last Round
- $15.0M Extension RoundMay 2023
- Rounds
- 2
About
NeuExcell Therapeutics is a clinical-stage gene-therapy company developing first-in-class treatments for neurodegenerative diseases. Its proprietary ATN Astrocytes To Neurons platform converts supporting glial cells into functional neurons at injury sites, with the aim of repairing damaged brain tissue. The company says it is advancing clinical trials in glioma, Alzheimer’s disease, and stroke, while evaluating the approach across additional neurological and ocular conditions.
Summary
Neuexcell Therapeutics is a Biotech company, founded in 2021. It has raised $25.0M in total across 2 rounds, most recently a $15.0M Extension Round round in May 2023. Investors include Cowin Ventures.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
May 2023
Sign up to see all 2 rounds
Extension Round — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/neuexcell-therapeutics"><img src="https://indexed.vc/api/badge/company/neuexcell-therapeutics" alt="Neuexcell Therapeutics on Indexed.vc" width="260" height="76" /></a>